From conventional formulations to nanoparticles in the delivery of Imiquimod: a literature review
{{output}}
Imiquimod (IMQ) is an FDA-approved immune response modifier available as a 5% w/w topical cream (Aldara™) and is extensively utilized in the treatment of superficial basal cell carcinoma and other skin cancers. PubMed and Google Scholar (2006-2026) were searc... ...
